Impact of coronavirus disease 2019 on adults in Najaf city
Department, of Pharmacology, Faculty of Pharmacy, University of Kufa, Najaf, Iraq.
Research Article
International Journal of Biological and Pharmaceutical Sciences Archive, 2025, 10(01), 229-245.
Article DOI: 10.53771/ijbpsa.2025.10.1.0066
Publication history:
Received on 26 June 2025; revised on 18 August; accepted on 27 August 2025
Abstract:
Covid-19 emerged in late 2019 in Wuhan, China, spreading globally and declared a pandemic by the WHO in March 2020. It primarily spreads through respiratory droplets, leading to mild flu-like symptoms or severe respiratory distress. Governments worldwide implemented measures like lockdowns, mask mandates, and vaccination campaigns to control its spread and mitigate its impact.
Aim of Study: was to assess the relationship between the infectious disease covid-19 and the adults population, especially elderly.
Method: We conducted an close-ended questionnaire to gather insights into the impact of covid-19 on adults. The survey targeted mainly individuals aged 60 and above. Participants were asked to voluntarily respond to a series of questions regarding their age, gender, chronic health conditions, vaccination status, etc. The survey received a total of 192 responses.
Results: Most participants above or below the age of sixty showed a higher infection rate among males. Chronic diseases such as hypertension and diabetes were common, and 14.1% reported being smokers. Urban areas were the main location of infection, with more than half of them being infected once. Over half of them received the vaccine, resulting in a more moderate response after infection. Infections typically lasted for two weeks or less, with sensory loss such as smell and taste impairment and difficulties in movement. 76.6% followed preventive measures, and most of them sought treatment. 58.3% experienced weight loss, and 62.5% reported loss of appetite. Many of them used protective measures such as dietary supplements and antibiotics.
Keywords:
Coronavirus; Adults; Najaf; Antibiotics
Full text article in PDF:
Copyright information:
Copyright © 2025 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0